Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antidepressive Agents

Known as: Antidepressant, Antidepressant Agent, Antidepressants 
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful… Expand
National Institutes of Health

Related topics

Related topics

46 relations
12 HR Carbamazepine 200 MG Extended Release Oral Capsule12 HR Carbamazepine 300 MG Extended Release Oral Capsule12 HR Carbamazepine 300 MG Extended Release Oral Capsule [Carbatrol]24 HR lamotrigine 200 MG Extended Release Oral Tablet [Lamictal]
Expand

Narrower (19)

ClomipramineMethylphenidateMoclobemideNialamide
Expand

Broader (1)

Pharmaceutical Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
  • Kenji Hashimoto
  • Psychiatry and clinical neurosciences
  • 2019
    • Corpus ID: 195065228
Major depressive disorder (MDD) is one of the most disabling psychiatric disorders. Approximately one‐third of the patients with… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2019
Review
2019
Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials
With growing interest in the gut microbiome, prebiotics and probiotics have received considerable attention as potential… Expand
Is this relevant?
Review
2019
Review
2019
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.
For decades, symptoms of depression have been treated primarily with medications that directly target the monoaminergic brain… Expand
Is this relevant?
Review
2018
Review
2018
Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications
Micronutrient deficiency and depression are major global health problems. Here, we first review recent empirical evidence of the… Expand
  • table 1
Is this relevant?
Review
2018
Review
2018
Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
There is a new appreciation of the perimenopause - defined as the early and late menopause transition stages as well as the early… Expand
Is this relevant?
Review
2017
Review
2017
BDNF/NF-κB Signaling in the Neurobiology of Depression.
BACKGROUND Mood disorders, consisting of unipolar and bipolar depression, are complex diseases characterized by depressed mood… Expand
Is this relevant?
Review
2017
Review
2017
Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications
Abstract Since their discovery in the mammalian brain, it has been apparent that serotonin (5-HT) and dopamine (DA) interactions… Expand
Is this relevant?
Review
2016
Review
2016
Ketamine abuse potential and use disorder
Ketamine is a noncompetitive antagonist of N-methyl-d-asparate (NMDA) receptor and has been long used as an anesthetic agent in… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Grading quality of evidence and strength of recommendations
Abstract Users of clinical practice guidelines and other recommendations need to know how much confidence they can place in the… Expand
Is this relevant?
Highly Cited
1979
Highly Cited
1979
A new depression scale designed to be sensitive to change.
The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described. Ratings of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE